MedTrace Logo

EVEREST-HN 1: EVolution of a patiEnt-REported Symptom-based Risk Stratification sySTem

NCT05909020 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 165

Last updated 2023-10-03

No results posted yet for this study

Summary

Can a patient-reported symptom-based risk stratification system improve the suspected head and neck cancer (HNC) pathway?

Our methodology includes six interlinked work packages to deliver our aim, with EVEREST-HN 1 encompassing the first of these and seeking to optimise a patient-reported symptom inventory for HNC and outline requirement specification for the SYmptom iNput Clinical (SYNC) system.

Conditions

Interventions

OTHER

No intervention.

No intervention.

Sponsors & Collaborators

  • University of Leeds

    collaborator OTHER

  • Royal Marsden NHS Foundation Trust

    lead OTHER

Principal Investigators

  • Vinidh Paleri · Royal Marsden NHS Foundation Trust

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-03-17
Primary Completion
2023-11-30
Completion
2023-11-30

Countries

  • United Kingdom

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05909020 on ClinicalTrials.gov